By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Arrayit today announced it is spinning out its majority-owned subsidiary Arrayit Diagnostics, which it expects to be listed on the Over-the-Counter Bulletin Board.

Arrayit will distribute its 78.18 percent interest in Arrayit Diagnostics as a stock dividend to its existing shareholders. The dividend distribution date and further details will be announced in the first quarter of 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.